Karyopharm Therapeutics Inc. - KPTI Income before deduction of interest, taxes and amortization

Graphic logo of karyopharm.com (KPTI)

Karyopharm Therapeutics (KPTI) operates a business that is insulated from market cycles, as demand for oncology drugs remains stable regardless of inflation. Optimized supply chains via reliable contractors eliminate distribution disruptions. High physician confidence in XPOVIO confirms the company's status as an expert in targeted therapy. Tracking EBITDA demonstrates a balance between supply and demand, where the 0.00 mark records this absolute operating profit figure.

Karyopharm Therapeutics, Inc. - KPTI Operating profit EBITDA (period 11/23/2025 - 11/16/2026)

Karyopharm (KPTI) - metric breakdowns and financial figures

- market value and analyst target forecast:
Summary company analytics:Karyopharm Therapeutics
Brand item of Karyopharm Therapeutics, Inc.

To assess the long-term sustainability of Karyopharm Therapeutics (KPTI), investors must analyze the daily cash inflow from core operations, calculated as operating cash flow minus non-recurring adjustments. Monitoring operating profit in cash terms helps identify the risk of declining demand, which is critical for a company whose clinical trials and biologics logistics are currently destabilized by geopolitical conflicts and sanctions.

Competitor analysis for Karyopharm Therapeutics

Genmab (GMAB) - Profit before interest, taxes and amortization|EXEL: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization NUVL (Nuvalent Corp)|KYMR (Kymera) - Operating profit before deduction of amortization|IDYA: Company profit before taxes, interest and amortization|ELVN (Enliven Corp) - Operating profit EBITDA|Operating profit EBITDA oricpharma.com|Profit before payment of interest, taxes and amortization Relay Therapeutics, Inc. (RLAY)|NRIX (Nurix Therapeutics, Inc.) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA TYRA (Tyra Biosciences Inc)|Operating profit before depreciation charges Verastem Inc|Monte Rosa Therapeutics Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Cullinan Therapeutics, Inc.|IMRX (Immuneering Corporation) - Operating profit before deduction of amortization|CCCC: Company profit before taxes, interest and amortization|BDTX (blackdiamondtherapeutics.com) - Operating profit EBITDA|Profit before interest, taxes and amortization Repare Rx RPTX|Operating profit EBITDA PMVP|Propanc Biopharma, Inc. - Operating profit before amortization|Bio Green Med Solution - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AADI|ALRN: Operating profit before deduction of amortization|blueprintmedicines.com - Company profit before taxes, interest and amortization|GLYC: Operating profit EBITDA|SpringWorks Therapeutics - Income before deduction of interest, taxes and amortization